Author:
Gao Jingtao,Du Jian,Shu Wei,Liu Yuhong,Wang Yufeng,Xue Zhongtan,Li Liang,Pang Yu
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference12 articles.
1. World Health Organization (2019) Global tuberculosis report 2019. Geneva: World Health Organization. WHO/HTM/TB/2019.13
2. Xu C, Pang Y, Li R, Ruan Y, Wang L, Chen M, Zhang H (2018) Clinical outcome of multidrug-resistant tuberculosis patients receiving standardized second-line treatment regimen in China. J Inf Secur 76:348–353
3. World Health Organization (2019) WHO consolidated guidelines on drug-resistant tuberculosis treatment. WHO, Geneva
4. Singh PK, Jain A (2019) Limited scope of shorter drug regimen for MDR TB caused by high resistance to fluoroquinolone. Emerg Infect Dis 25:1760–1762
5. Pang Y, Zhang Z, Wang Y, Wang S, Song Y, Zhao B, Zhou Y, Ou X, Li Q, Xia H, Zheng Y, Fang X, Zhao Y (2017) Genotyping and prevalence of pyrazinamide- and moxifloxacin-resistant tuberculosis in China, 2000 to 2010. Antimicrob Agents Chemother 61
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献